ESR1 and neoplasm: As a consequence of the limitations of the study, the relatively low number of patients with detectable ER-positive CTCs, the relatively short follow-up time, and heterogeneity in sample collection time-points in our study, an association with survival or clinical variables such as tumor burden and grade could not be made with ER status of CTCs yet.